{"version":"1.0","provider_name":"Matribhumi Samachar English","provider_url":"https:\/\/matribhumisamachar.com\/en","author_name":"Saransh Kanaujia","author_url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/","title":"Theralase(R) Releases 2Q2025 Financial Statements - Matribhumi Samachar English","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"DocavTk6IN\"><a href=\"https:\/\/matribhumisamachar.com\/en\/2025\/08\/27\/theralaser-releases-2q2025-financial-statements\/\">Theralase(R) Releases 2Q2025 Financial Statements<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/matribhumisamachar.com\/en\/2025\/08\/27\/theralaser-releases-2q2025-financial-statements\/embed\/#?secret=DocavTk6IN\" width=\"600\" height=\"338\" title=\"&#8220;Theralase(R) Releases 2Q2025 Financial Statements&#8221; &#8212; Matribhumi Samachar English\" data-secret=\"DocavTk6IN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/matribhumisamachar.com\/en\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Toronto, Ontario&#8211;(Newsfile Corp. &#8211; August 26, 2025) &#8211; Theralase\u00ae Technologies Inc.\u00a0(TSXV: TLT) (OTCQB: TLTFF)\u00a0(&#8220;Theralase\u00ae&#8221; or the &#8220;Company&#8220;), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses has released the Company&#8217;s unaudited condensed consolidated interim 2Q2025 financial statements (&#8220;Financial Statements&#8220;). Theralase\u00ae will be hosting a conference &hellip;","thumbnail_url":"https:\/\/api.newsfilecorp.com\/newsinfo\/263978\/511"}